shelter pharma has scheduled an investor conference call to discuss the audited financial results for the half year and year ended March 31, 2026. The meeting is set to take place on Wednesday, June 10, 2026, at 3:30 PM IST. The management will provide business and operational updates during the session.

The conference call will be led by Mustaqim Nisarahmed Sabugar, Managing Director of the company. The discussion will focus on the financial performance for H2 and FY26. The company noted that the meeting may be cancelled, rescheduled, or postponed due to exigencies on the part of analysts, investors, or company officials.

Conference Call Details

The event will be conducted virtually through the Zoho Meeting platform. Investors and analysts can join the session using the specific dial-in details provided below.

Shelter Pharma Ltd has been operating in the natural healthcare sector since 1965, focusing on Ayurveda and modern research. The company develops herbal solutions aimed at holistic wellness.

Shelter Pharma has obtained Good Manufacturing Practice (GMP) certification for its Ayurvedic manufacturing plant, with the certification valid until 2030. This regulatory recognition underscores the company's compliance with established quality and manufacturing standards applicable to Ayurvedic pharmaceutical production.

GMP Certification Details

The following table summarizes the key details of the certification:

Significance of the Certification

GMP certification is a critical regulatory requirement for pharmaceutical and Ayurvedic manufacturers, ensuring that products are consistently produced and controlled in accordance with quality standards. The certification for Shelter Pharma's Ayurvedic manufacturing plant confirms that the facility meets the requisite norms set by the relevant regulatory authorities. The validity of the certification extending until 2030 provides the company with a defined operational window under this regulatory approval.